Analyses of the skin molecules in patients with Parkinson's disease.
Not Applicable
- Conditions
- Parkinson's disease
- Registration Number
- JPRN-UMIN000032982
- Lead Sponsor
- Kao Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1.Panelists who use the drug for the treatment of Parkinson's disease 2.Panelists who have the type I or II diabetes. 3.Panelists who have the malignant tumors or history of them. 4.Panelists who have the skin diseases, such as atopic dermatitis, acne vulgaris, and psoriasis vulgaris. 5.Panelists who have the infectious diseases, such as HIV, HCV, HIV, and syphilis. 6.Panelists who use the antibiotics within 2 weeks before participation in this study. 7.Panelists who use the prescription drugs having any effects to this study. 8.Panelists who use the prescription topical agents on the face
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The relationship between skin molecules and states of Parkinson's disease.
- Secondary Outcome Measures
Name Time Method The relationship of the molecules between skin and blood.